Promiscuous T-cell responses to drugs and drug-haptens - 06/08/15
F.S.Y. is a PhD student funded by the Medical Research Council; Integrative Toxicology Training Programme (MRC ITTP) initiative. S.-H.K. received a Marie-Curie International Incoming Fellowship grant to support her studies in the United Kingdom (Project 298395; Chic-FILI). The project received core funding from the MRC Centre for Drug Safety Science (grant no. G0700654) and also the Mechanism-based integrated systems for the prediction of drug-induced liver injury project (supported by the European Community under the Innovative Medicines Initiative Programme through grant agreement no. 115336). |
|
Disclosure of potential conflict of interest: A. K. Daly has consultant arrangements with Servier. M. Pirmohamed has received research support from the Medical Research Council Centre for Drug Safety Science. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 136 - N° 2
P. 474 - Agosto 2015 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?